Alleima AB (publ) (STO:ALLEI)
Sweden flag Sweden · Delayed Price · Currency is SEK
68.50
-0.85 (-1.23%)
Aug 1, 2025, 5:29 PM CET

CTI BioPharma Revenue

Alleima AB had revenue of 4.77B SEK in the quarter ending June 30, 2025, a decrease of -11.08%. This brings the company's revenue in the last twelve months to 19.51B, down -1.26% year-over-year. In the year 2024, Alleima AB had annual revenue of 19.69B, down -4.73%.

Revenue (ttm)
19.51B
Revenue Growth
-1.26%
P/S Ratio
0.88
Revenue / Employee
3.04M
Employees
6,309
Market Cap
17.14B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202419.69B-978.00M-4.73%
Dec 31, 202320.67B2.26B12.30%
Dec 31, 202218.41B4.56B32.92%
Dec 31, 202113.85B-78.00M-0.56%
Dec 31, 202013.93B-1.73B-11.05%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition